OTC Markets OTCPK - Delayed Quote
USD
Adaptimmune Therapeutics plc (ADAPY)
0.0190
-0.0010
(-5.00%)
At close: November 5 at 4:00:00 PM EST
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Christopher James Hill ACA, BA (Hons)
|
CEO, CFO, Secretary & Director | 76.62k | -- | 1980 |
|
Dr. Helen Katrina Tayton-Martin MBA, Ph.D.
|
Co-Founder | 677.4k | -- | 1967 |
|
Dr. Juli P. Miller Ph.D.
|
VP of Corporate Affairs & Investor Relations | -- | -- | -- |
|
Ms. Dana Lynch
|
Senior Director of Corporate Communications | -- | -- | -- |
|
Ms. Kimberly Freeman
|
Vice President of Commercial Planning | -- | -- | -- |
|
Laura Gunn
|
Vice President of Medical Affairs | -- | -- | -- |
Adaptimmune Therapeutics plc
The Innovation Centre
99 Park Drive, Milton Park
Abingdon, OX14 4RY
United Kingdom
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 272
Description
Adaptimmune Therapeutics plc engages in research, development, and subsequent manufacture and commercialisation of cell therapies to treat cancer in the United States and the United Kingdom. The company was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
Corporate Governance
Adaptimmune Therapeutics plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
November 13, 2025 at 12:00 AM UTC
15-12G: Notice of termination of registration of a class of securities under Section 12(g)
October 28, 2025 at 12:00 AM UTC
25: Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
